MedTrace Logo

Umbilical Cord Serum Eye Drops

NCT01016158 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2009-11-19

No results posted yet for this study

Summary

In the present study, the investigators investigated the efficacy of umbilical cord serum eye drops for the treatment of patients with recurrent corneal erosions. Group A were treated with 20% umbilical cord serum eye drops 3 to 4 times a day in addition to artificial tears, and group B were treated with artificial tears only. Ophthalmic examinations including visual acuity measurement and slit lamp biomicroscopy were performed before and every month after treatment. Recurrence was defined as the presence of clinical symptoms accompanied by epithelial defects in the cornea.

Conditions

  • Recurrent Corneal Erosion

Interventions

DRUG

Umbilical cord serum eyedrops

20% umbilical cord serum eye drops 3 to 4 times a day

Sponsors & Collaborators

  • Chonnam National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2009-04-30
Completion
2009-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01016158 on ClinicalTrials.gov